Prazosin dynamics in hypertension: relationship to plasma concentration

Area of Science:

• Pharmacology
• Cardiovascular Medicine

Background:

• Prazosin is an alpha-1 blocker used for hypertension.
• Understanding prazosin's pharmacokinetic-pharmacodynamic relationship is crucial for optimizing treatment.

Purpose of the Study:

• To investigate the antihypertensive effects of prazosin in relation to its plasma kinetics.
• To assess the correlation between prazosin dosage, plasma concentrations, and blood pressure reduction.

Main Methods:

• Single intravenous and oral doses of prazosin (0.5 mg) were administered.
• Multiple increasing oral doses (0.5 to 5 mg TID) were given.
• Blood pressure (systolic and diastolic) and plasma prazosin concentrations were monitored.

Main Results:

• Prazosin caused a 10-14% fall in blood pressure, greater when standing.
• Prazosin plasma concentrations correlated with dose and antihypertensive effect after IV administration.
• Correlation between mean plasma concentration and antihypertensive effect was inconsistent during multiple dosing.
• Initial oral dose response predicted later steady-state response, suggesting limited early identification of responders.

Conclusions:

• Prazosin exhibits dose-dependent antihypertensive effects related to its plasma kinetics.
• Predicting individual patient response to chronic prazosin therapy based on early doses is difficult.
• No significant blood pressure overshoot or enhanced hypotensive effect was observed upon withdrawal and re-challenge.